You are here : Home / All Sectors / Miscellaneous / Miscellaneous / SUN PHARMA ADVANCED RESEARCH COMPANY LTD

SUN PHARMA ADVANCED RESEARCH COMPANY LTD Analysis

Returns | 1W : -2.6% , 1M : 1.2%,1Y : 2%
BOM : 532872     NSE : SPARC    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jan 22,2021
Price(EOD): Rs. 181.80
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
Industry : Miscellaneous
MarketCap: Rs. 4,763.16 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY LTD -2.6% 1.2% 2%
SYNGENE INTERNATIONAL LTD -0.2% -5.1% 97.3%
QUESS CORP LTD -5.5% 18.4% -1.2%
SECURITY AND INTELLIGENCE SERVICES INDIA LTD -2.3% -9.2% -19.6%
TEAMLEASE SERVICES LTD 2.4% 10.7% 1.9%
DELTA CORP LTD -1.9% -7% -25.1%
JUST DIAL LTD -0% 7.2% 11.1%
HEALTHCARE GLOBAL ENTERPRISES LTD 0.3% -5.9% 48.7%
FERMENTA BIOTECH LTD -2.9% -7% -2.5%

FUNDAMENTAL ANALYSIS OF SUN PHARMA ADVANCED RESEARCH COMPANY LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SUN PHARMA ADVANCED RESEARCH COMPANY LTDPremium

As on 22-Jan-2021, the Fundamentals of SUN PHARMA ADVANCED RESEARCH COMPANY LTD are Poor and hence it's not good for long term investment ! See Financial Performance of SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF SUN PHARMA ADVANCED RESEARCH COMPANY LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
-
P/E Calculated based on EPS of -11.92
[ Mar2020 - Standalone Results ]

-
P/B Calculated based on Book Value of -0.71
[ Mar2020 - Standalone Results ]

19.45
P/S Calculated based on Revenues of 244.95 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SUN PHARMA ADVANCED RESEARCH COMPANY LTDPremium

As on 22-Jan-2021, SUN PHARMA ADVANCED RESEARCH COMPANY LTD is Under Valued and hence a good buying opportunity according to Share Valuation at this time!


INTRINSIC VALUE OF SUN PHARMA ADVANCED RESEARCH COMPANY LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
-53%
-54%

As on 22-Jan-2021, the Intrinsic Value of SUN PHARMA ADVANCED RESEARCH COMPANY LTD is Rs. 392.89 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. -3,004.91
Fair Value based on Median EV / Sales Model : Rs. 390.67
Fair Value based on Median Price / Sales Model : Rs. 395.10
Median Fair Value of SUN PHARMA ADVANCED RESEARCH COMPANY LTD : Rs. 392.89

As on 22-Jan-2021, SUN PHARMA ADVANCED RESEARCH COMPANY LTD is trading at a Discount of -54% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF SUN PHARMA ADVANCED RESEARCH COMPANY LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
-3.67
0.01
0.02
-1.21
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
1.9 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-90.49%
-229.48%
-247.28%
-247.28%
2.62%
31.14%
32.19%
32.19%
QtrlyTrend
0
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z